癌症相关性血栓临床治疗现状与进展  

Current status and progresses of clinical treatment of cancer-associated thromboembolism

作　　者：狄英杰 薛耀勤[2] 欧爱鑫 李肖 任金锐 DI Yingjie;XUE Yaoqin;OU Aixin;LI Xiao;REN Jinrui(Department of Interventional Therapy,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Interventional Therapy,Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital,Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University,Taiyuan 030013,China;Academy of Medical Sciences,Shanxi Medical University,Jinzhong 030600,China)

机构地区：[1]国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院介入治疗科,北京100021 [2]山西省肿瘤医院/中国医学科学院肿瘤医院山西分院/山西医科大学附属肿瘤医院介入治疗科,山西太原030013 [3]山西医科大学医学科学院,山西晋中030600

出　　处：《中国介入影像与治疗学》2024年第5期298-301,共4页Chinese Journal of Interventional Imaging and Therapy

基　　金：国家自然科学基金(82330061)。

摘　　要：癌症相关性血栓(CAT)是恶性肿瘤常见并发症及患者第二大直接死亡原因,严重影响患者生活质量及预后。近年来,随着癌症及血栓形成机制相关研究的不断深入,CAT治疗策略不断进步。本文就临床治疗CAT现状与进展进行综述。Cancer-associated thromboembolism(CAT)is one of the most common complications and the second direct cause of mortality in patients with malignant tumors,which seriously affect patients’life quality and prognosis.In recent years,with the deepening of mechanism researches of cancer and thrombosis,treatment strategies of CAT were also improved.The current status and progresses of clinical treatment of CAT were reviewed in this article.

关 键 词：肿瘤 血栓栓塞 

分 类 号：R730.6[医药卫生—肿瘤]